Neko Health, a London-based health scanning company, has secured $700 million in Series C funding. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, with notable investors including Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. This influx of capital values Neko Health's valuation at $3.5 billion, according to sources close to the company.
The Numbers
Neko Health has developed proprietary body-scanning technology that integrates with Apple Health data to provide users with a comprehensive health assessment. The company has seen significant traction, with over 100,000 people having had scans at its locations in the U.K. and Sweden. Moreover, more than 350,000 people have either registered for the waitlist or set an appointment at Neko Health.
The Backstory
Neko Health was founded by Daniel Ek, co-founder of Spotify, and Hjalmar Nilsonne, a Swedish entrepreneur. The company's mission is to transform the way people approach their health and wellness. Ek and Nilsonne's vision is to make health scanning accessible to everyone, and with this latest funding round, they are one step closer to achieving that goal.
What's Next
As Neko Health prepares to open its first U.S. location in New York, the company is well-positioned to become a leader in the health and wellness industry. With its advanced technology and growing user base, Neko Health is poised to capitalize on the growing demand for its services. However, the company will face competition from other health scanning companies, including Midjourney, which is also developing body-scanning technology. As Neko Health expands its operations, it will be interesting to see how the company maintains its competitive edge.
